New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Sutro Biopharma, Inc.
STRO
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

148M

Biotechnology

Next Earning date - 24 Mar 2025

148M

Biotechnology

Next Earning date - 24 Mar 2025

1.79USD

Shape-0.20 ( -10.05%)
Market Closed (as of Feb 11, 00:48 EDT)
favorite-chart

Relative Strenght

6
favorite-chart

Volume Buzz

85%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

71%

Quote Panel

Shape
Updated February 11, 2025
1W -11.82 % 1M 0.00 % 3M -56.13 % 1Y -63.32 %

Key Metrics

Shape
  • Market Cap

    147.60M


  • Shares Outstanding

    82.46M


  • Share in Float

    76.30M


  • Dividende

    0


  • Earning Date

    24 Mar 2025


  • Price Target

    1.79


  • Average Volume

    1.06M


  • Beta

    1.168


  • Range

    1.67-6.13


  • Industry

    Biotechnology


  • Website

    https://www.sutrobio.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

STRO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$49M

Shape477%

2025-Revenue

$3.04

Shape-415%

2025-EPS

$39M

Shape-1%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.61
vs -0.83

Q1.23

arrow
arrow

N/A

NA
vs -0.84

Q2.23

arrow
arrow

N/A

NA
vs -0.55

Q3.23

arrow
arrow

N/A

-0.81
vs -0.37

Q4.23

arrow
arrow

+169%

0.42
vs -0.61

Q1.24

arrow
arrow

N/A

NA
vs NA

Q2.24

arrow
arrow

N/A

NA
vs NA

Q3.24

arrow
arrow

N/A

-0.59
vs -0.81

Q4.24

arrow
arrow

N/A

-0.83
vs 0.42

Q1.25

arrow
arrow

N/A

-0.85
vs NA

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-19%

8.6M  vs 10.7M

Q1.23

arrow
arrow

+115%

12.7M  vs 5.9M

Q2.23

arrow
arrow

-63%

10.4M  vs 28.1M

Q3.23

arrow
arrow

-33%

16.9M  vs 25.1M

Q4.23

arrow
arrow

+1217%

113.7M  vs 8.6M

Q1.24

arrow
arrow

+3%

13M  vs 12.7M

Q2.24

arrow
arrow

+147%

25.7M  vs 10.4M

Q3.24

arrow
arrow

-50%

8.5M  vs 16.9M

Q4.24

arrow
arrow

-89%

12.2M  vs 113.7M

Q1.25

arrow
arrow

-31%

9M  vs 13M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-17%

-0.17
vs -0.08

Q1.23

arrow
arrow

-27%

-0.27
vs -0.17

Q2.23

arrow
arrow

-25%

-0.25
vs -0.27

Q3.23

arrow
arrow

-44%

-0.44
vs -0.25

Q4.23

arrow
arrow

+21%

0.21
vs -0.44

Q1.24

arrow
arrow

-59%

-0.59
vs 0.21

Q2.24

arrow
arrow

-32%

-0.32
vs -0.59

Q3.24

arrow
arrow

-44%

-0.44
vs -0.32

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

120

120
vs 112

7%

Q1.23

arrow
arrow

116

116
vs 120

-3%

Q2.23

arrow
arrow

121

121
vs 116

4%

Q3.23

arrow
arrow

110

110
vs 121

-9%

Q4.23

arrow
arrow

114

114
vs 110

4%

Q1.24

arrow
arrow

118

118
vs 114

4%

Q2.24

arrow
arrow

122

122
vs 118

3%

Q3.24

arrow
arrow

134

134
vs 122

10%

Earnings Growth

Latest News